So the earnings crunch continues, and here's a look at some companies scheduled to report results this week that are anticipated to be big winners and losers in terms of earnings growth.
Analysts surveyed by Thomson Financial expect the following to report strong earnings growth when compared to the same period of the previous year.
Apache Corp. (NYSE: APA): $4.10 EPS (+53.9%) on revenue of $3.8 billion (+54.6%)
EOG Resources Inc. (NYSE: EOG): $2.34 EPS (+50.0%) on revenue of $1.7 billion (+62.2%)
Avon Products Inc. (NYSE: AVP): $0.47 EPS (+44.7%) on revenue of $2.6 billion (+11.5%)
It is not very many chips, but it means a great deal, especially from a PR standpoint. Intel (NASDAQ: INTC) has taken the processor franchise at Dreamworks from smaller rival AMD (NYSE: AMD). Dreamworks indicated that the Intel products worked much better, a public slap at the incumbent.
According toThe Wall Street Journal, "DreamWorks Animation said the resulting increase in computing power would substantially shorten the time needed for many computing chores and aid the studio's planned shift next year to 3-D animation." Given how good the press is for Intel, it should be giving the chips to Dreamworks for free. Perhaps that is how it got the contract.
Intel's new eight-core chips are extremely powerful and this should be of real benefit to Dreamworks.
The news is another demonstration of how bad things are at AMD. The company still has over $5 billion in debt and barely breaks even on an operating basis. Its shares are just above $5. In 2006, they were above $40.
AMD can ill afford having its name on the front page matched with another customer loss.
Douglas A. McIntyre is an editor at 247wallst.com.
Steven Spielberg's DreamWorks baby is preparing to leave Viacom (NYSE: VIA). That sounds bad, doesn't it? I mean, Viacom should, in theory, be freaked out about losing the star asset.
Yet, an analyst working at JP Morgan has a different take on things. According to Bloomberg, Imran Khan thinks that DreamWorks may be perceived as an expensive business asset. He pointed out that the expenses associated with DreamWorks helped drive a 22% decline in operating income for Viacom's film division in 2007. He further pointed out that films with more modest budgets will aid in generating better returns and will, in fact, reduce the risk of investing in the movie business.
Khan is absolutely correct on his call. I've been talking about the need to reduce film budgets for a long time now, probably to the point where people are sick of me, so I'm always glad when I read an opinion such as this. Only problem is, will the studios listen? Well, they should. Disney (NYSE: DIS), Time Warner (NYSE: TWX), News Corp. (NYSE: NWS), and Sony (NYSE: SNE) would all benefit from increased financial restraint when it comes to the business plans of their respective film units.
Steven Spielberg and his DreamWorks Animation SKG Inc (NYSE: DWA) partners are close to signing a deal with India's Reliance ADA Group for between $500M and $600M that would provide financing to the company as it prepares to leave Viacom Inc's (NYSE: VIA) Paramount Pictures this year, the Wall Street Journal reported. DreamWorks will seek to obtain an additional $500M in debt financing to make about six new films a year.
The Wall Street Journal also reported that at an investor update yesterday, The Hershey Company (NYSE: HSY) CEO David West said the chocolate-bar maker would boost spending on marketing about 20% this year and next, and slightly increased the company's long-term annual sales targets. West offered little detail on how Hershey will address its reliance on the U.S. market for revenue.
OTHER PAPERS:
The Economic Times reported that India's Maneesh Pharmaceuticals, a mid-sized company, bought a 51% stake in U.S.-based Synovics Pharmaceuticals Inc (OTC: SYVC). The terms of the deal were not disclosed.
The Economic Times also reported that General Electric Company's (NYSE: GE) GE Money Financial Services, which was seeking a parter for its personal and home loan portfolios, may have called off the process after it was unable to get the right valuation.
Bob Nardelli, the chairman and CEO of Chrysler LLC, sent a memo to employees warning them of worsening U.S. sales, the Detroit News reported. The e-mail did not indicate the auto maker would look to soon further cut production or lay off staff, a person familiar with the matter said.
Steven Spielberg and his high-powered friends at DreamWorks may have found financing to leave the Paramount division of Viacom (NYSE:VIA). According toThe Wall Street Journal, Reliance ADA of India "would provide Mr. Spielberg and company with $500 million to $600 million in equity."
About a year ago, Viacom management said that DreamWorks was not a "material" part of Viacom. From a financial standpoint that may or may not be true. But, there are not many stars in the movie business with the credentials of Mr. Spielberg, who has made some of the most successful movies in the history of film.
The potential departure from Viacom of some of its top talent is telling. Large media companies are now so significantly challenged by competition, especially from the internet, that the idea of keeping big names at a price may no longer have much appeal.
In the age of user-created content and sites like YouTube, who needs movie stars to get eyeballs? The audience for video is moving away from movies which cost $200 million to make.
Douglas A. McIntyre is an editor at 247wallst.com.
Steven Spielberg wants to reboot the DreamWorks brand, according to this article. He's not happy being at Viacom's (NYSE: VIA) Paramount and not having full ownership of his films. What he wants to do now is see if he can summon $1 billion in financing to catalyze this new phase in his life.
Of course, the phrase "see if he can" is probably not the most accurate one to use when talking about Spielberg. When it comes to Hollywood, his word is scripture, and if he asks for financing, he'll have more takers than he can handle. After raising his billion bucks, Spielberg needs to decide which studio will be a perfect home for his new celluloid ambitions. Although the article states that there is a possibility he can land anywhere, to me, there's no ambiguity whatsoever.
Spielberg will end up at General Electric's (NYSE: GE) Universal (if I could be as sure about the price of oil as I am about Spielberg and Universal, I'd be a rich, rich man). He and his Amblin shingle have had a long relationship with Universal, and simply put, that's where he wants to be. It's funny to consider Disney (NYSE: DIS) and News Corp. (NYSE: NWS) as potential new homes for DreamWorks. Disney definitely wouldn't want him since the Mouse is being very conservative in terms of film making, and although News Corp. would love to overpay for him (I think News Corp. enjoys overpaying for things at times), I just don't see Spielberg going to Fox.
Since last year's summer movie preview featured mostly sequels and adaptations, this year's preview has been expanded to include more than just potential "blockbusters." The following is a chronological list of not only the most hyped film fare of the summer, but other noteworthy smaller entries, and a short commentary on each.
5/2 - Iron Man, Viacom (NYSE: VIA)'s Paramount Pictures The first of two big Marvel Entertainment (NYSE: MVL) adaptations of the summer, the Robert Downey Jr. led Iron Man has been getting a ton of hype and critical acclaim. This is the second year that a comic book adaptation has kicked off the summer, following last year's Spider-Man 3, which grossed over $150M over its opening weekend.
5/9 - Speed Racer, Time Warner (NYSE: TWX)'s Warner Bros. Another big-budget adaptation of a generations-old cartoon. Last year's Transformers was, to my surprise, a huge success, so maybe Speed Racer, in the capable directing hands of the Wachowskis, can be as well.
Dreamworks (NYSE: DWA) Kung-Fu Panda is scheduled to open nationally on June 6. DWA is scheduled to report Q1 EPS on April 29. Stifel Nicolaus has a Buy rating and a price target of $31 on DWA. DWA May option implied volatility of 46 is above its 26-week average of 40 according to Track Data, suggesting larger price risk.
Options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.
MOST NOTEWORTHY: Dreamworks Animation, Pharmasset and Vertex Pharmaceuticals were today's noteworthy initiations:
Jefferies initiated Dreamworks Animation (NYSE: DWA) with a Hold rating and $25 target. The firm believes the company needs stronger-than-expected box office performance to drive material share appreciation, which they view as a risky bet given recent non-Shrek film performance, slower DVD sales and a tough economy.
Merriman assumed coverage of Pharmasset (NASDAQ: VRUS) with a Buy rating, as they believe the current share price does not adequately reflect the company's strong clinical data, potential for clinical milestones, or potential for revenue generation. They believe shares could trade to a fair value range of $20-24 in the next 12 months.
Merriman initiated shares of Vertex Pharmaceutials (NASDAQ: VRTX) with a Neutral rating, and recommends investors hold pending a greater understanding of clinical timelines and results for other HCV drug candidates.
Next year Nestle USA will sell Jamba Inc's (NASDAQ: JMBA) Jamba Juice at stores in eight states in the western U.S., according to the Wall Street Journal.
Last May Canadian information provider The Thomson Corporation (NYSE: TOC) bought Reuters Group Plc (NASDAQ: RTRSY) for GBP8.7B. While the deal was beneficial to Reuters, the credit crunch could have a severe impact on its bottom line over the next few years, the Wall Street Journal's "Heard on the Street" said.
Jeffrey Zucker, General Electric Company's (NYSE: GE) NBC Universal media unit would be interested in DreamWorks SKG if it were to become available, Bloomberg reported.
MOST NOTEWORTHY: Cypress Bioscience, Banc of America, Insulet, Taleo and Vocus Inc were today's noteworthy initiations:
Friedman Billings started shares of Cypress Biosciences Inc (NASDAQ: CYPB) with an Outperform rating and $22 target, and is positive on the company's lead product milnacipran, in Phase III studies for fibromyalgia. The firm expects a 1Q09 launch and believes the U.S. market could be as large as $7B.
Goldman resumed coverage of Bank of America Corporation (NYSE: BAC) with a Buy rating and $63 target as they believe the company has around $22.5B of unrealized gains in its strategic investment portfolio. Goldman also added BAC to their Americas Buy List.
Insulet Corporation (NASDAQ: PODD) was initiated at William Blair with an Outperform rating. The firm believes the unique features of the OmniPod will allow PODD to capture a meaningful portion of the 300,000 current insulin pumpers in the United States.
Soleil started shares of Taleo Corporation (NASDAQ: TLEO) with a Buy rating and $35 target and believes the company's recent growth pace can continue.
Shares of Vocus Inc (NASDAQ: VOCS) were also initiated at Soleil with a Buy rating and $39 target. The firm believes the company can gain share in the early stage market for public relations software given its on-demand model and low price entry point.
Boyd Gaming(NYSE:BYD) calls active on renewed & unconfirmed buyout chatter. BYD is recently up $0.68 to $43.37. BYD has a market cap of $3.7 billion with long term debt of $2.1 billion. BYD had quarterly June 2007 revenues of $511 million. BYD call option volume of 3,763 contracts compares to put volume of 105 contracts. BYD October option implied volatility of 38 is above its 26-week average of 34 according to Track Data, suggesting larger price risk.
Dreamworks(NYSE:DWA) calls active on unconfirmed buyout chatter: 'Bee Movie' out 11/2. DWA is recently up $0 .10 cents to $32.95. Unconfirmed buyout chatter is circulating today. Goldman Sachs said on 9/19 "we continue to rate DWA Buy as we believe the four films of 2007/2008 will raise investors' perception of normalized earnings." The Bee Movie is expected to be released on 11/2. DWA October 35 calls have traded 47 times on transaction volume of 897 contracts above its open interest of 344 contracts. DWA October option implied volatility of 36 is above its 26-week average of 30 according to Track Data, suggesting larger price risk.
Daily Options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.